Avalo Therapeutics grants 78,000 inducement stock options priced at $19.34 per share
AVTX•Vesting terms and award plan
Vesting starts with 25% after one year from each employee’s start date, then continues monthly over 36 months.
The awards were issued under the company’s 2025 Inducement Award Plan.
Inducement stock options granted to new hires
Avalo Therapeutics granted nonstatutory stock options covering 78,000 shares to six newly hired employees.
The options were issued on Sept. 2, 2026 with an exercise price of $19.34 per share, set at the closing price.
